9 pending office actions • 8 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (11%) |
| §101 + other | 2 (22%) |
| §103 only | 2 (22%) |
| §112 only | 2 (22%) |
| Multi-statute (no §101) | 2 (22%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAHAND, SANA | 1 | 63.4% | +24.5% |
| HALVORSON, MARK | 1 | 48.1% | +21.6% |
| PAGUIO FRISING, MICHELLE F | 1 | 70.8% | +40.5% |
| KOVACH, KARA NICOLE | 1 | 85.7% | +100.0% |
| POPA, ILEANA | 1 | 21.5% | +14.6% |
| BUNKER, AMY M | 1 | 29.1% | +45.3% |
| LAFAVE, ELIZABETH ROSE | 1 | 59.6% | +45.2% |
| BAUSCH, SARAE L | 1 | 29.6% | +44.4% |
| BEHARRY, ZANNA MARIA | 1 | 23.2% | +52.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17906115 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING GLUTAMINASE INHIBITOR-SENSITIVE CANCERS | BAUSCH, SARAE L | 118d overdue |
| 19197587 | METHOD AND DEVICE TO PREDICT EXERCISE PEAK VO2, CARDIOVASCULAR OUTCOMES AND FUTURE DEATH USING ECG DEEP LEARNING MODELS | SAHAND, SANA | 32d overdue |
| 18446945 | COMPOSITIONS FOR DETECTING SECRETION AND METHODS OF USE | POPA, ILEANA | 26d |
| 18580579 | COMPOSITIONS AND METHODS FOR CHARACTERIZING A COMPLEX BIOLOGICAL SAMPLE | KOVACH, KARA NICOLE | — |
| 18266555 | METHODS FOR DUPLEX REPAIR | BUNKER, AMY M | — |
| 17615579 | REPRODUCIBLE BRAIN ORGANOIDS AND METHODS OF MAKING | BEHARRY, ZANNA MARIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17906115 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING GLUTAMINASE INHIBITOR-SENSITIVE CANCERS | BAUSCH, SARAE L | 118d overdue |
| 19197587 | METHOD AND DEVICE TO PREDICT EXERCISE PEAK VO2, CARDIOVASCULAR OUTCOMES AND FUTURE DEATH USING ECG DEEP LEARNING MODELS | SAHAND, SANA | 32d overdue |
| 19074044 | FORMULATIONS FOR NEOPLASIA VACCINES | HALVORSON, MARK | 5d |
| 18446945 | COMPOSITIONS FOR DETECTING SECRETION AND METHODS OF USE | POPA, ILEANA | 26d |
| 18690382 | SUBSTRATES AND BIOMARKERS OF ADAMTS7 | PAGUIO FRISING, MICHELLE F | — |
| 18580579 | COMPOSITIONS AND METHODS FOR CHARACTERIZING A COMPLEX BIOLOGICAL SAMPLE | KOVACH, KARA NICOLE | — |
| 18266555 | METHODS FOR DUPLEX REPAIR | BUNKER, AMY M | — |
| 17927112 | NUCLEIC ACID ARTIFICIAL MINI-PROTEOME LIBRARIES | LAFAVE, ELIZABETH ROSE | — |
| Art Unit | Apps |
|---|---|
| 1684 | 2 |
| 3796 | 1 |
| 1646 | 1 |
| 1651 | 1 |
| 1681 | 1 |
| 1633 | 1 |
| 1699 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19197587 | METHOD AND DEVICE TO PREDICT EXERCISE PEAK VO2, CARDIOVASCULAR OUTCOMES AND FUTURE DEATH USING ECG DEEP LEARNING MODELS | SAHAND, SANA | 3796 | §101 | Non-Final OA | 32d overdue | Pending | May 02, 2025 |
| 19074044 | FORMULATIONS FOR NEOPLASIA VACCINES | HALVORSON, MARK | 1646 | §112 | Final Rejection | 5d | Pending | Mar 07, 2025 |
| 18690382 | SUBSTRATES AND BIOMARKERS OF ADAMTS7 | PAGUIO FRISING, MICHELLE F | 1651 | §112 | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18580579 | COMPOSITIONS AND METHODS FOR CHARACTERIZING A COMPLEX BIOLOGICAL SAMPLE | KOVACH, KARA NICOLE | 1681 | §101§103§112 | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18446945 | COMPOSITIONS FOR DETECTING SECRETION AND METHODS OF USE | POPA, ILEANA | 1633 | §103 | Final Rejection | 26d | Pending | Aug 09, 2023 |
| 18266555 | METHODS FOR DUPLEX REPAIR | BUNKER, AMY M | 1684 | §102§103§112 | Non-Final OA | — | Pending | Jun 09, 2023 |
| 17927112 | NUCLEIC ACID ARTIFICIAL MINI-PROTEOME LIBRARIES | LAFAVE, ELIZABETH ROSE | 1684 | §103 | Non-Final OA | — | Pending | Nov 22, 2022 |
| 17906115 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING GLUTAMINASE INHIBITOR-SENSITIVE CANCERS | BAUSCH, SARAE L | 1699 | §101§102§112 | Non-Final OA | 118d overdue | Pending | Sep 12, 2022 |
| 17615579 | REPRODUCIBLE BRAIN ORGANOIDS AND METHODS OF MAKING | BEHARRY, ZANNA MARIA | 1632 | §103§112 | Final Rejection | — | Pending | Nov 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial